Asylia Diagnostics Company
Asylia Diagnostics - precision medicine data platform for immunotherapies
Headquarters:
Delaware City, Delaware, United States
Last Funding Type:
Series B
Investors Number:
2.0
Last Funding Date:
2020-03-02
Employee Number:
45200
Total Funding:
1100000.0
Founded Date:
2019-08-22
Technology:
['BioTech & HealthTech']
Estimated Revenue:
Less than $1M
Investor Type:
andrey.khmelevskiy@asyliadx.com
Industry:
Medical BioTech
Funding Status:
Seed